Astrocyte and Alzheimer's disease

Area of Science:

• Neuroscience
• Neurobiology
• Cellular Biology

Background:

• Astrocytes, crucial glial cells, have increasingly recognized roles in brain function and disease.
• Their involvement in Alzheimer's disease (AD) can be either neuroprotective or detrimental.
• Astrocytic impairments and responses to injury can worsen key AD pathologies, including amyloid-beta and tau.

Purpose of the Study:

• This review synthesizes current understanding of astrocyte involvement in Alzheimer's disease (AD) pathogenesis.
• It specifically examines the mechanisms by which astrocytes influence amyloid-beta (Aβ) pathology and neurofibrillary tangle (NFT) formation.
• The review also explores the contribution of astrocytic metabolic dysfunction to AD onset and clinical symptoms.

Main Methods:

• Literature review and synthesis of existing research on astrocyte function in AD.
• Analysis of mechanisms related to amyloid-beta (Aβ) generation, clearance, and neurofibrillary tangle (NFT) formation.
• Examination of the role of astrocytic metabolic dysfunction in AD pathogenesis.

Main Results:

• Astrocytes significantly influence both the generation and clearance of amyloid-beta (Aβ).
• Astrocytic dysfunction is implicated in the formation of amyloid plaques and neurofibrillary tangles (NFTs).
• Metabolic disturbances in astrocytes are identified as an initiating factor and contributor to the clinical presentation of AD.

Conclusions:

• Astrocytes are key players in Alzheimer's disease, impacting Aβ and tau pathologies.
• Astrocytic metabolic dysfunction is a critical factor in AD initiation and progression.
• Targeting astrocyte function presents a potential therapeutic avenue for Alzheimer's disease.